Isovitexin Depresses Osteoarthritis Progression via the Nrf2/NF-κB Pathway: An in vitro Study

Xiaofen Hu,1,2,* Ruijie Li,1,2,* Ming Sun,1,2 Ying Kong,1,2 Haifeng Zhu,1,2 Fujiang Wang,1 Quanqing Wan1,2 1The Third Affiliated Hospital of Zhejiang Chinese Medicine University, Hangzhou, 310005, People’s Republic of China; 2Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hu X, Li R, Sun M, Kong Y, Zhu H, Wang F, Wan Q
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/f60b76eaa48e4435881988aa324f0a6f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f60b76eaa48e4435881988aa324f0a6f
record_format dspace
spelling oai:doaj.org-article:f60b76eaa48e4435881988aa324f0a6f2021-12-02T18:06:28ZIsovitexin Depresses Osteoarthritis Progression via the Nrf2/NF-κB Pathway: An in vitro Study1178-7031https://doaj.org/article/f60b76eaa48e4435881988aa324f0a6f2021-04-01T00:00:00Zhttps://www.dovepress.com/isovitexin-depresses-osteoarthritis-progression-via-the-nrf2nf-kappab--peer-reviewed-article-JIRhttps://doaj.org/toc/1178-7031Xiaofen Hu,1,2,* Ruijie Li,1,2,* Ming Sun,1,2 Ying Kong,1,2 Haifeng Zhu,1,2 Fujiang Wang,1 Quanqing Wan1,2 1The Third Affiliated Hospital of Zhejiang Chinese Medicine University, Hangzhou, 310005, People’s Republic of China; 2Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, 310053, People’s Republic of China*These authors contributed equally to this workCorrespondence: Quanqing WanThe Third Affiliated Hospital of Zhejiang Chinese Medicine University, 219 Moganshan Road, Hangzhou, 310005, Zhejiang, People’s Republic of ChinaEmail 13003678819@163.comPurpose: Osteoarthritis (OA) is a multifactorial joint disease and inflammatory processes contribute to joint destruction. Isovitexin (IVX) is a flavone component found in passion flower, Cannabis and, and the palm that is known for its anti-inflammatory properties.Materials and Methods: This study investigated in vitro the role and underlying mechanism used by IVX in its regulation of OA development. Effects of IVX on the viability of chondrocytes were measured by CCK-8 assays. The phenotypes of extracellular matrix (ECM) degeneration and inflammation were measured by qPCR, Western blot, and ELISA; and NF-κB pathway was detected by immunofluorescence and Western blot. Molecular docking was applied to predict the interacting protein of IVX, while Nrf2 was knocked down by siRNAs to confirm its role.Results: We demonstrated that IVX suppressed ECM degeneration and suppressed pro-inflammatory factors in IL-1β-treated chondrocytes. Additionally, IVX impact on NF-κB signaling in IL-1β-exposed chondrocytic cells; Mechanistically, it was also demonstrated in molecular docking and knock down studies that IVX might bind to Nrf2 to suppress NF-κB pathway.Conclusion: Our data suggest that IVX halts OA disease advancement through the Nrf2/NF-κB axis, suggesting a possibility of IVX as a target for OA therapy.Keywords: osteoarthritis, isovitexin, extracellular matrix, NF-κB, Nrf2Hu XLi RSun MKong YZhu HWang FWan QDove Medical Pressarticleosteoarthritisisovitexinextracellular matrixnf-κbnrf2.PathologyRB1-214Therapeutics. PharmacologyRM1-950ENJournal of Inflammation Research, Vol Volume 14, Pp 1403-1414 (2021)
institution DOAJ
collection DOAJ
language EN
topic osteoarthritis
isovitexin
extracellular matrix
nf-κb
nrf2.
Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
spellingShingle osteoarthritis
isovitexin
extracellular matrix
nf-κb
nrf2.
Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
Hu X
Li R
Sun M
Kong Y
Zhu H
Wang F
Wan Q
Isovitexin Depresses Osteoarthritis Progression via the Nrf2/NF-κB Pathway: An in vitro Study
description Xiaofen Hu,1,2,* Ruijie Li,1,2,* Ming Sun,1,2 Ying Kong,1,2 Haifeng Zhu,1,2 Fujiang Wang,1 Quanqing Wan1,2 1The Third Affiliated Hospital of Zhejiang Chinese Medicine University, Hangzhou, 310005, People’s Republic of China; 2Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, 310053, People’s Republic of China*These authors contributed equally to this workCorrespondence: Quanqing WanThe Third Affiliated Hospital of Zhejiang Chinese Medicine University, 219 Moganshan Road, Hangzhou, 310005, Zhejiang, People’s Republic of ChinaEmail 13003678819@163.comPurpose: Osteoarthritis (OA) is a multifactorial joint disease and inflammatory processes contribute to joint destruction. Isovitexin (IVX) is a flavone component found in passion flower, Cannabis and, and the palm that is known for its anti-inflammatory properties.Materials and Methods: This study investigated in vitro the role and underlying mechanism used by IVX in its regulation of OA development. Effects of IVX on the viability of chondrocytes were measured by CCK-8 assays. The phenotypes of extracellular matrix (ECM) degeneration and inflammation were measured by qPCR, Western blot, and ELISA; and NF-κB pathway was detected by immunofluorescence and Western blot. Molecular docking was applied to predict the interacting protein of IVX, while Nrf2 was knocked down by siRNAs to confirm its role.Results: We demonstrated that IVX suppressed ECM degeneration and suppressed pro-inflammatory factors in IL-1β-treated chondrocytes. Additionally, IVX impact on NF-κB signaling in IL-1β-exposed chondrocytic cells; Mechanistically, it was also demonstrated in molecular docking and knock down studies that IVX might bind to Nrf2 to suppress NF-κB pathway.Conclusion: Our data suggest that IVX halts OA disease advancement through the Nrf2/NF-κB axis, suggesting a possibility of IVX as a target for OA therapy.Keywords: osteoarthritis, isovitexin, extracellular matrix, NF-κB, Nrf2
format article
author Hu X
Li R
Sun M
Kong Y
Zhu H
Wang F
Wan Q
author_facet Hu X
Li R
Sun M
Kong Y
Zhu H
Wang F
Wan Q
author_sort Hu X
title Isovitexin Depresses Osteoarthritis Progression via the Nrf2/NF-κB Pathway: An in vitro Study
title_short Isovitexin Depresses Osteoarthritis Progression via the Nrf2/NF-κB Pathway: An in vitro Study
title_full Isovitexin Depresses Osteoarthritis Progression via the Nrf2/NF-κB Pathway: An in vitro Study
title_fullStr Isovitexin Depresses Osteoarthritis Progression via the Nrf2/NF-κB Pathway: An in vitro Study
title_full_unstemmed Isovitexin Depresses Osteoarthritis Progression via the Nrf2/NF-κB Pathway: An in vitro Study
title_sort isovitexin depresses osteoarthritis progression via the nrf2/nf-κb pathway: an in vitro study
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/f60b76eaa48e4435881988aa324f0a6f
work_keys_str_mv AT hux isovitexindepressesosteoarthritisprogressionviathenrf2nfkappabpathwayaninvitrostudy
AT lir isovitexindepressesosteoarthritisprogressionviathenrf2nfkappabpathwayaninvitrostudy
AT sunm isovitexindepressesosteoarthritisprogressionviathenrf2nfkappabpathwayaninvitrostudy
AT kongy isovitexindepressesosteoarthritisprogressionviathenrf2nfkappabpathwayaninvitrostudy
AT zhuh isovitexindepressesosteoarthritisprogressionviathenrf2nfkappabpathwayaninvitrostudy
AT wangf isovitexindepressesosteoarthritisprogressionviathenrf2nfkappabpathwayaninvitrostudy
AT wanq isovitexindepressesosteoarthritisprogressionviathenrf2nfkappabpathwayaninvitrostudy
_version_ 1718378668109070336